Gene · 1854
Papers1,394
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,394
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Temporal dynamics, microdiversity, and ecological functions of viral communities during cyanobacterial blooms in Lake Taihu. | NPJ Biofilms Microbiomes | 2025 | 40883308 | PubTator, text mining | PubMed |
| Viral Reprogramming of Nucleotide Synthesis and Its Impact on Viral Infection. | J Med Virol | 2025 | 40832900 | PubTator, text mining | PubMed |
| Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening. | ACS Pharmacol Transl Sci | 2025 | 40810141 | PubTator, text mining | PubMed |
| HHV-6 and EBV reactivation in relapsing remitting multiple sclerosis: Disability, progression, and inflammation links. | iScience | 2025 | 40740493 | PubTator, text mining | PubMed |
| Cooperative CCL2/CCR2 and HGF/MET signaling enhances breast cancer growth and invasion associated with metabolic reprogramming. | Cancer Biol Ther | 2025 | 40736024 | PubTator, text mining | PubMed |
| Identification and profiling of novel metagenome assembled uncultivated virus genomes from human gut. | Virol J | 2025 | 40713701 | PubTator, text mining | PubMed |
| A de-embedding method based on combining time and frequency domains. | Sci Rep | 2025 | 40436968 | PubTator, text mining | PubMed |
| Reactivation of Latent Herpesviruses and a Faulty Antiviral Response may Contribute to Chronic Multi-Symptom and Multi-System Illnesses in U.S. Military Veterans. | J Med Virol | 2025 | 40392130 | PubTator, text mining | PubMed |
| Investigating Cisplatin Resistance in Squamous Cervical Cancer: Proteomic Insights into DNA Repair Pathways and Omics-Based Drug Repurposing. | J Proteome Res | 2025 | 40298920 | PubTator, text mining | PubMed |
| Extending the Traceability of Dynamic Calibration to the High-Pressure Regime Using a Shock Tube. | Sensors (Basel) | 2025 | 40285142 | PubTator, text mining | PubMed |
| Full-length inhibitor protein is the most effective to perturb human dUTPase activity. | Sci Rep | 2025 | 39924564 | PubTator, text mining | PubMed |
| Structural analysis of dUTPase from Helicobacter pylori reveals unusual activity for dATP. | Int J Biol Macromol | 2024 | 39490855 | PubTator, text mining | PubMed |
| Structural dynamics of human deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase). | Sci Rep | 2024 | 39477983 | PubTator, text mining | PubMed |
| Structural definition of pseudorabies virus dUTPase reveals a novel folding dimer in the herpesvirus family. | Int J Biol Macromol | 2024 | 39284464 | PubTator, text mining | PubMed |
| G0 arrest gene patterns to predict the prognosis and drug sensitivity of patients with lung adenocarcinoma. | PLoS One | 2024 | 39159158 | PubTator, text mining | PubMed |
| In-silico evaluation of Oroxylum indicum vent compounds in the plausible treatment and prevention of nasopharyngeal cancer. | J Ayurveda Integr Med | 2024 | 38805854 | PubTator, text mining | PubMed |
| Leucoma salicis nucleopolyhedrovirus (LesaNPV) genome sequence shed new light on the origin of the Alphabaculovirus orpseudotsugatae species. | Virus Genes | 2024 | 38594489 | PubTator, text mining | PubMed |
| Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome. | Acta Neuropsychiatr | 2024 | 38571295 | PubTator, text mining | PubMed |
| Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12. | J Immunother Cancer | 2024 | 38527762 | PubTator, text mining | PubMed |
| The emerging roles of non-canonical ubiquitination in proteostasis and beyond. | J Cell Biol | 2024 | 38517379 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1854/papers?page=2